Stay updated on PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial

Sign up to get notified when there's something new on the PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A banner announces NIH website updates and says that some NIH content may use “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-25T17:15:57.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.1 to v3.7.2. The study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T22:11:58.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-11T22:09:37.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The page previously showing a 403 Forbidden error now loads the full study record for NCT03447678, including the study overview, eligibility criteria, and locations. Additional metadata sections such as IPD sharing plans and relevant MeSH terms were added to enhance contextual information and searchability.
    Difference
    70%
    Check dated 2026-09-27T20:57:26.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content. Access to the study details is blocked, and the usual information is replaced by an error screen.
    Difference
    21%
    Check dated 2026-09-20T22:16:38.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page footer shows a new revision label: v3.6.6 replaced v3.6.5. This reflects a minor template or system update that does not alter the study details or documented content.
    Difference
    0.0%
    Check dated 2026-08-30T15:45:43.000Z thumbnail image

Stay in the know with updates to PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial page.